Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

"ChopNSpice," a mass spectrometric approach that allows identification of endogenous small ubiquitin-like modifier-conjugated peptides.

Hsiao HH, Meulmeester E, Frank BT, Melchior F, Urlaub H.

Mol Cell Proteomics. 2009 Dec;8(12):2664-75. doi: 10.1074/mcp.M900087-MCP200. Epub 2009 Aug 31.

2.

Accessing ns-micros side chain dynamics in ubiquitin with methyl RDCs.

Far├Ęs C, Lakomek NA, Walter KF, Frank BT, Meiler J, Becker S, Griesinger C.

J Biomol NMR. 2009 Sep;45(1-2):23-44. doi: 10.1007/s10858-009-9354-7. Epub 2009 Aug 4.

3.

The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo.

van der Horst EH, Frank BT, Chinn L, Coxon A, Li S, Polesso F, Slavin A, Ruefli-Brasse A, Wesche H.

Neoplasia. 2008 Apr;10(4):340-7.

4.

Tumor necrosis factor-alpha-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells.

Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC.

J Biol Chem. 2004 Feb 13;279(7):5612-20. Epub 2003 Nov 18.

5.
6.

Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.

Frank BT, Rossall JC, Caughey GH, Fang KC.

J Immunol. 2001 Feb 15;166(4):2783-92.

Supplemental Content

Loading ...
Support Center